Los Angeles Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Los Angeles Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,494	Closed	-$291K	–	1301
2024 Q1	$291K	Buy	+18,494	New	+$285K	﹤0.01%	1015
2023 Q3	–	Sell	-13,435	Closed	-$189K	–	1260
2023 Q2	$189K	Sell	13,435 -4,683	-26%	-$67K	﹤0.01%	1120
2023 Q1	$280K	Buy	+18,118	New	+$303K	﹤0.01%	1028
2022 Q4	–	Sell	-10,970	Closed	-$203K	–	1300
2022 Q3	$203K	Hold	10,970	–	–	﹤0.01%	1168
2022 Q2	$144K	Buy	10,970 +390	+4%	+$4.3K	﹤0.01%	1281
2022 Q1	$98K	Buy	+10,580	New	+$90K	﹤0.01%	1390
2021 Q2	–	Sell	-8,075	Closed	-$362K	–	1701
2021 Q1	$362K	Sell	8,075 -4,566	-36%	-$213K	﹤0.01%	1365
2020 Q4	$721K	Buy	12,641 +380	+3%	+$22.5K	﹤0.01%	1065
2020 Q3	$629K	Buy	12,261 +8,110	+195%	+$397K	﹤0.01%	996
2020 Q2	$248K	Buy	+4,151	New	+$222K	﹤0.01%	1342

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Los Angeles Capital Management's DCPH Position: Q2 2024 in Review

Los Angeles Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 18,494 shares — an estimated $291K sold.

Los Angeles Capital Management first reported a position in DCPH in Q2 2020 and held it in 10 quarters. The position peaked at $721K in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Los Angeles Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Los Angeles Capital Management sold 18,494 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $291K.
Los Angeles Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Los Angeles Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $721K in Q4 2020.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Los Angeles Capital Management's 13F filing for Q2 2024, filed 5 Aug 2024.